Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience

References

• D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med. 2011;365(25):2398–2411
   PubMed Web of Science ®Google Scholar
• Cravedi P, Kopp JB, Remuzzi G. Recent progress in the pathophysiology and treatment of FSGS recurrence. Am J Transplant. 2013;13(2):266–274
   PubMed Web of Science ®Google Scholar
• Moriconi L, Lenti C, Puccini R, et al. Proteinuria in focal segmental glomerulosclerosis: Role of circulating factors and therapeutic approach. Ren Fail. 2001;23(3–4):533–541
   PubMed Web of Science ®Google Scholar
• Zimmerman SW. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin Nephrol. 1984;22(1):32–38
   PubMed Web of Science ®Google Scholar
• Dantal J, Bigot E, Bogers W, et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med. 1994;330(1):7–14
   PubMed Web of Science ®Google Scholar
• Wei C, El Hindi S, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011;17(8):952–960
   PubMed Web of Science ®Google Scholar
• Zimmerman SW. Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis. Nephron. 1985;40(2):241–245
   PubMedGoogle Scholar
• Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol. 2010;5(12):2363–2372
   PubMed Web of Science ®Google Scholar
• Sanchez AP, Cunard R, Ward DM. The selective therapeutic apheresis procedures. J Clin Apher. 2013;28(1):20–29
   PubMed Web of Science ®Google Scholar
• Belak M, Borberg H, Jimenez C, et al. Technical and clinical experience with protein A immunoadsorption columns. Transfus Sci. 1994;15:419–422
   PubMedGoogle Scholar
• Levey AS, Greene T, Beck GJ, et al. Dietary protein restriction and the progression of chronic renal disease: What have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol. 1999;10(11):2426–2439
   PubMed Web of Science ®Google Scholar
• Ichikawa I, Ma J, Motojima M, et al. Podocyte damage damages podocytes: Autonomous vicious cycle that drives local spread of glomerular sclerosis. Curr Opin Nephrol Hypertens. 2005;14(3):205–210
   PubMed Web of Science ®Google Scholar
• Ohta T, Kawaguchi H, Hattori M, et al. Effect of pre- and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation. 2001;71(5):628–633
   PubMed Web of Science ®Google Scholar
• Gohh RY, Yango AF, Morrissey PE, et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant. 2005;5(12):2907–2912
   PubMed Web of Science ®Google Scholar
• Dall'Amico R, Ghiggeri G, Carraro M, et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis. 1999;34(6):1048–1055
   PubMed Web of Science ®Google Scholar
• Laufer J, Ettenger RB, Ho WG, et al. Plasma exchange for recurrent nephrotic syndrome following renal transplantation. Transplantation. 1988;46(4):540–542
   PubMed Web of Science ®Google Scholar
• Kawaguchi H, Hattori M, Ito K, et al. Recurrence of focal glomerulosclerosis of allografts in children: The efficacy of intensive plasma exchange therapy before and after renal transplantation. Transplant Proc. 1994;26(1):7–8
   PubMed Web of Science ®Google Scholar
• Mowry J, Marik J, Cohen A, et al. Treatment of recurrent focal segmental glomerulosclerosis with high-dose cyclosporine A and plasmapheresis. Transplant Proc. 1993;25(1 Pt 2):1345–1346
   PubMed Web of Science ®Google Scholar
• Cochat P, Kassir A, Colon S, et al. Recurrent nephrotic syndrome after transplantation: Early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol. 1993;7(1):50–54
   PubMed Web of Science ®Google Scholar
• Cheong HI, Han HW, Park HW, et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2000;15(1):78–81
   PubMed Web of Science ®Google Scholar
• Saleem MA, Ramanan AV, Rees L. Recurrent focal segmental glomerulosclerosis in grafts treated with plasma exchange and increased immunosuppression. Pediatr Nephrol. 2000;14(5):361–364
   PubMed Web of Science ®Google Scholar
• Pradhan M, Petro J, Palmer J, et al. Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol. 2003;18(9):934–938
   PubMed Web of Science ®Google Scholar
• Häffner K, Zimmerhackl LB, von Schnakenburg C, et al. Complete remission of post-transplant FSGS recurrence by long-term plasmapheresis. Pediatr Nephrol. 2005;20(7):994–997
   PubMed Web of Science ®Google Scholar
• Garcia CD, Bittencourt VB, Tumelero A, et al. Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis. Transplant Proc. 2006;38(6):1904–1905
   PubMed Web of Science ®Google Scholar
• Fencl F, Simková E, Vondrák K, et al. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: Case reports. Transplant Proc. 2007;39(10):3488–3490
   PubMed Web of Science ®Google Scholar
• Canaud G, Zuber J, Sberro R, et al. Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: A pilot study. Am J Transplant. 2009;9(5):1081–1086
   PubMed Web of Science ®Google Scholar
• Canaud G, Martinez F, Noël LH, et al. Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients. Transplant Rev. 2010;24(3):121–128
   Google Scholar
• Shishido S, Satou H, Muramatsu M, et al. Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation. Clin Transplant. 2013;27(2):E143–E150
   PubMed Web of Science ®Google Scholar
• Sethna C, Benchimol C, Hotchkiss H, et al. Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: Effect of rituximab. J Transplant. 2011;2011:389542
   PubMedGoogle Scholar
• Stewart ZA, Shetty R, Nair R, et al. Case report: Successful treatment of recurrent focal segmental glomerulosclerosis with a novel rituximab regimen. Transplant Proc. 2011;43(10):3994–3996
   PubMed Web of Science ®Google Scholar
• Balogun RA, Ogunniyi A, Sanford K, et al. Therapeutic apheresis in special populations. J Clin Apher. 2010;25(5):265–274
   PubMed Web of Science ®Google Scholar
• Terman DS, Tavel T, Petty D, et al. Specific removal of antibody by extracorporeal circulation over antigen immobilized in collodion-charcoal. Clin Exp Immunol. 1977;28(1):180–188
   PubMed Web of Science ®Google Scholar
• Terman DS, Buffaloe G, Mattioli C, et al. Extracorporeal immunoadsorption: Initial experience in human systemic lupus erythematosus. Lancet. 1979;2(8147):824–827
   PubMed Web of Science ®Google Scholar
• Shimizu A, Higo S, Fujita E, et al. Focal segmental glomerulosclerosis after renal transplantation. Clin Transplant. 2011;25(Suppl 23):6–14
   PubMed Web of Science ®Google Scholar
• Vinai M, Waber P, Seikaly MG. Recurrence of focal segmental glomerulosclerosis in renal allograft: An in-depth review. Pediatr Transplant. 2010;14(3):314–325
   PubMed Web of Science ®Google Scholar
• Dantal J, Baatard R, Hourmant M, et al. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects. Transplantation. 1991;52(5):827–831
   PubMed Web of Science ®Google Scholar
• Greenstein SM, Delrio M, Ong E, et al. Plasmapheresis treatment for recurrent focal sclerosis in pediatric renal allografts. Pediatr Nephrol. 2000;14(12):1061–1065
   PubMed Web of Science ®Google Scholar
• Cochat P, Schell M, Ranchin B, et al. Management of recurrent nephrotic syndrome after kidney transplantation in children. Clin Nephrol. 1996;46(1):17–20
   PubMed Web of Science ®Google Scholar
• Beaudreuil S, Zhang X, Kriaa F, et al. Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2014;29(2):458–1456
   PubMed Web of Science ®Google Scholar
• Alachkar N, Wei C, Arend LJ, et al. Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. Transplantation. 2013;96(7):649–656
   PubMed Web of Science ®Google Scholar
• Cho JH, Lee JH, Park GY, et al. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient. Ren Fail. 2014;36(4):623–626
   PubMed Web of Science ®Google Scholar
• Hickson LJ, Gera M, Amer H, et al. Kidney transplantation for primary focal segmental glomerulosclerosis: Outcomes and response to therapy for recurrence. Transplantation. 2009;87(8):1232–1239
   PubMed Web of Science ®Google Scholar
• Meyer TN, Thaiss F, Stahl RA. Immunoadsorption and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transplant Int. 2007;20(12):1066–1071
   PubMed Web of Science ®Google Scholar
• Kamar N, Faguer S, Esposito L, et al. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Clin Nephrol. 2007;67(4):250–254
   PubMed Web of Science ®Google Scholar
• Park HS, Hong Y, Sun IO, et al. Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients. Korean J Intern Med. 2014;29(4):482–488
   PubMed Web of Science ®Google Scholar
• Tejani AT, Butt K, Trachtman H, et al. Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int. 1988;33(3):729–734
   PubMed Web of Science ®Google Scholar
• Le Berre L, Godfrin Y, Perretto S, et al. The Buffalo/Mna rat, an animal model of FSGS recurrence after renal transplantation. Transplant Proc. 2001;33(7–8):3338–3340
   PubMed Web of Science ®Google Scholar
• Faul C, Donnelly M, Merscher-Gomez S, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med. 2008;14(9):931–938
   PubMed Web of Science ®Google Scholar
• Salomon R, Gagnadoux MF, Niaudet P. Intravenous cyclosporine therapy inrecurrent nephrotic syndrome after renal transplantation in children. Transplantation. 2003;75(6):810–814
   PubMed Web of Science ®Google Scholar
• Raafat RH, Kalia A, Travis LB, et al. High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis. 2004;44(1):50–56
   PubMed Web of Science ®Google Scholar
• Shalhoub RJ. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet. 1974;2(7880):556–560
   PubMed Web of Science ®Google Scholar